Task: Answer the multiple-choice question.
Query: Which drug exhibits a -3.593% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: Cc1ccc(NC(=O)c2ccco2)cc1NC(=O)CSc1nnc(-c2cccs2)n1C
b: CCOC(=O)/C(C#N)=C/C1=C(N2CCOCC2)CC(C)(C)OC1
Answer: b. CCOC(=O)/C(C#N)=C/C1=C(N2CCOCC2)CC(C)(C)OC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)/C(C#N)=C/C1=C(N2CCOCC2)CC(C)(C)OC1
CCOC(=O)/C(C#N)=C/C1=C(N2CCOCC2)CC(C)(C)OC1
ethyl (E)-2-cyano-3-(6,6-dimethyl-4-morpholin-4-yl-2,5-dihydropyran-3-yl)prop-2-enoate